abrdn Healthcare Opportunities Fund
THQ- Exchange
- NYSE
- SEC CIK
- 0001604522
In the last 90 days, abrdn Healthcare Opportunities Fund insiders filed 1 open-market purchase and 0 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $152.8M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $10.5K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +9 vs. previous quarter
- 96
- 13F valueReported value at the end of Q2 2026
- $152.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding THQ, Q2 2026
No superinvestor reported holding THQ at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by abrdn Healthcare Opportunities Fund insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)2:31 PM ET | Jul 16 | 4 days | Mahai Chris LaVictoireDirector | PPurchase | +568 | $18.49 | +$10.5K | New position568 after | |
| Jul 18, 2024 (view filing) | Jul 16 | 2 days | DiMartino RoseDirector | PPurchase | +1.00K | $21.30 | +$21.3K | New position1.00K after | |
| Apr 12, 2024 (view filing) | Apr 9 | 3 daysLate | Goetz KathleenDirector | PPurchase | +600 | $19.54 | +$11.7K | +109.5%1.15K after | |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Reit ToddDirector | PPurchase | +1.00K | $18.44 | +$18.4K | New position1.00K after | |
| Jan 2, 2024 (view filing) | Dec 28, 2023 | 5 days | Maher BillDirector | PPurchase | +1.00K | $18.25 | +$18.3K | New position1.00K after | |
| Mar 24, 2022 (view filing) | Mar 23 | 1 day | Goetz KathleenDirector | PPurchaseShares of Beneficial Interest | +69.19 | $21.69 | +$1.50K | +14.4%548.19 after | |
| Jan 27, 2022 (view filing) | Jan 26 | 1 day | Goetz KathleenDirector | PPurchaseShares of Beneficial Interest | +479 | $21.73 | +$10.4K | New position479 after |
Top 10 13F holders, Q2 2026
The largest institutional positions in abrdn Healthcare Opportunities Fund at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,436,568 | $26.9M | 0.00% | +90,362+6.7% | Added |
| Royal Bank of Canada | 1,108,986 | $20.8M | 0.00% | −34,778−3.0% | Reduced |
| Raymond James Financial Inc | 726,863 | $13.6M | 0.00% | −56,823−7.3% | Reduced |
| Heron Bay Capital Management | 562,344 | $10.5M | 0.95% | −32,027−5.4% | Reduced |
| Penserra Capital Management LLC | 464,627 | $8.70M | 0.07% | +17,692+4.0% | Added |
| LPL Financial LLC | 346,884 | $6.50M | 0.00% | +39,830+13.0% | Added |
| Ameriprise Financial Inc | 203,590 | $3.82M | 0.00% | +13,706+7.2% | Added |
| UBS Group AG | 196,425 | $3.68M | 0.00% | −111,799−36.3% | Reduced |
| Wedbush Securities Inc | 187,779 | $3.52M | 0.09% | +14,272+8.2% | Added |
| First Trust Advisors LP | 147,949 | $2.77M | 0.00% | +5,991+4.2% | Added |